Fibronectin induces MMP2 expression in human prostate cancer cells

Biochemical and Biophysical Research Communications

Volumn 430, Issue 4, 2013, Pages 1319-1321

  Moroz, Andrei ^a   Delella, Flávia K ^a   Lacorte, Lívia M ^a   Deffune, Elenice ^a   Felisbino, Sérgio L ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Fibronectin; LNCaP; MMP2; MMP9; PC 3; RWPE 1

Indexed keywords

FIBRONECTIN; GELATIN; GELATINASE A; PLASMA PROTEIN;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL STRAIN LNCAP; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; ZYMOGRAPHY;

CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; FIBRONECTINS; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROSTATIC NEOPLASMS;

EID: 84872871834     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.12.031     Document Type: Article

References (21)

1. Jemal A., Siegel R., Xu J., et al. Cancer statistics, 2010, CA. Cancer J. Clin. 2010, 60:277-300.
2. Kirby M., Hirst C., Crawford E.D. Characterizing the castration-resistant prostate cancer population: a systematic review. Int. J. Clin. Pract. 2011, 65:1180-1192.
3. Myung J.K., Sadar M.D. Large scale phosphoproteome analysis of LNCaP human prostate cancer cells. Mol. Biosyst. 2012, 8:2174-2182.
4. O'Connor K.C. Three-dimensional cultures of prostatic cells: tissue models for the development of novel anti-cancer therapies. Pharm. Res. 1999, 4:486-493.
5. Coulson-Thomas V.J., Gesteira T.F., Coulson-Thomas Y.M., et al. Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation. Exp. Cell. Res. 2010, 316:3207-3226.
6. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92:827-839.
7. Deryugina E.I., Quigley J.P. Matrix metalloproteinases and tumor metastasis. Cancer Metast. Rev. 2006, 25:9-34.
8. Zhang J., Jung K., Lein M., et al. Differential expression of matrix metalloproteinases and their tissue inhibitors in human primary cultured prostatic cells and malignant prostate cell lines. Prostate 2002, 50:38-45.
9. Daja M.M., Niu X., Zhao Z., et al. Characterization of expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in prostate cancer cell lines. Prost. Cancer Prostatic Dis. 2003, 6:15-26.
10. Docheva D., Padula D., Schieker M., et al. Effect of collagen I and fibronectin on the adhesion, elasticity and cytoskeletal organization of prostate cancer cells. Biochem. Biophys. Res. Commun. 2010, 402:361-366.
11. Thomas F., Holly J.M., Persad R., et al. Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: involvement of the insulin like growth factor-1 receptor. Prostate 2010, 70:856-865.
12. Fornaro M., Plescia J., Chheang S., et al. Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J. Biol. Chem. 2003, 278:50402-50411.
13. Malik G., Knowles L.M., Dhir R., et al. Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion. Cancer Res. 2010, 70:4327-4334.
14. Thompson I.M., Klein E.A., Lippman S.M., et al. Prevention of prostate cancer with finasteride: US/European perspective. Eur. Urol. 2003, 44:650-655.
15. Delella F.K., Justulin L.A., Felisbino S.L. Finasteride treatment alters MMP-2 and -9 gene expression and activity in the rat ventral prostate. Int. J. Androl. 2010, 33:114-122.
16. Das S., Banerji A., Frei E., et al. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells (MCF-7) to fibronectin in serum free medium. Life Sci. 2008, 82:467-476.
17. Meng X.N., Jin Y., Yu Y., et al. Characterization of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br. J. Cancer 2009, 101:327-334.
18. Pentyala S.N., Whyard T.C., Waltzer W.C., et al. Androgen induction of urokinase gene expression in LNCaP cells is dependent on their interaction with the extracellular matrix. Cancer Lett. 1998, 130:121-126.
19. Plow E.F., Herren T., Redlitz A., et al. The cell biology of the plasminogen system. FASEB J. 1995, 9:939-945.
20. Mauviel A. Cytokine regulation of metalloproteinase gene expression. J. Cell Biochem. 1993, 53:288-295.
21. Liao X., Thrasher J.B., Pelling J., et al. Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer. Endocrinology 2003, 144:1656-1663.